Literature DB >> 15717313

Negative acting HLH proteins Id 1, Id 2, Id 3, and Id 4 are expressed in prostate epithelial cells.

Jaideep Chaudhary1, Michelle Schmidt, Ingrid Sadler-Riggleman.   

Abstract

BACKGROUND: The four known Id proteins, Id 1, Id 2, Id 3, and Id 4 are largely considered as dominant negative helix-loop-helix (HLH) proteins. They can dimerize with basic helix loop proteins (bHLH) but the dimers fail to bind the consensus E box response element (CANNTG). Alternatively, members of the Id family, for example, Id 2 can also bind to non-bHLH proteins such as retinoblastoma (Rb) and ETS-TCF to modulate their activities. Consistent with their role as promoters of proliferation, subset of Id genes for example, Id 1 and Id 2 are expressed in many cancers including that of the prostate. However, their expression and function in the normal prostate is unknown.
METHODS: The present study was designed to evaluate the expression profile and functional significance of all Id isoforms in normal rat prostate epithelial cells. The data suggests that all four Id isoforms are expressed in normal cells, albeit at different levels.
RESULTS: Agents that promote growth, for example, serum increase the levels of Id 1, Id 2, and Id 3. The hormones and mitogens such as testosterone and hepatocyte growth factor (HGF) that promote prostate epithelial cell differentiation stimulate Id 4 and Id 2, respectively.
CONCLUSIONS: In prostate epithelial cells, Id 1 may be specifically involved in promoting proliferation whereas Id 4 and Id 2 may have defined roles in regulating differentiated functions in response to androgens and local paracrine factors such as HGF. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717313     DOI: 10.1002/pros.20238

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  10 in total

1.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

2.  The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.

Authors:  J Chaudhary; M Schmidt
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

Review 3.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

Review 4.  My what big eyes you have: how the Drosophila retina grows.

Authors:  Justin P Kumar
Journal:  Dev Neurobiol       Date:  2011-12       Impact factor: 3.964

5.  Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.

Authors:  Daniel Delitto; Dongyu Zhang; Song Han; Brian S Black; Andrea E Knowlton; Adrian C Vlada; George A Sarosi; Kevin E Behrns; Ryan M Thomas; Xiaomin Lu; Chen Liu; Thomas J George; Steven J Hughes; Shannon M Wallet; Jose G Trevino
Journal:  Clin Cancer Res       Date:  2015-12-14       Impact factor: 12.531

6.  Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.

Authors:  Jugal Bharat Joshi; Divya Patel; Derrick J Morton; Pankaj Sharma; Jin Zou; Dhanushka Hewa Bostanthirige; Yamini Gorantla; Peri Nagappan; Shravan Kumar Komaragiri; Jeffrey C Sivils; Huan Xie; Ravi Palaniappan; Guangdi Wang; Marc B Cox; Jaideep Chaudhary
Journal:  Mol Oncol       Date:  2017-03-02       Impact factor: 6.603

7.  Inhibitor of differentiation 1 (ID1) promotes cell survival and proliferation of prostate epithelial cells.

Authors:  Michelle Schmidt; Ananthi J Asirvatham; Jaideep Chaudhary
Journal:  Cell Mol Biol Lett       Date:  2010-02-25       Impact factor: 5.787

8.  Environmental Toxicant Induced Epigenetic Transgenerational Inheritance of Prostate Pathology and Stromal-Epithelial Cell Epigenome and Transcriptome Alterations: Ancestral Origins of Prostate Disease.

Authors:  Rachel Klukovich; Eric Nilsson; Ingrid Sadler-Riggleman; Daniel Beck; Yeming Xie; Wei Yan; Michael K Skinner
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

9.  Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.

Authors:  Jason P W Carey; Ananthi J Asirvatham; Oliver Galm; Tandeih A Ghogomu; Jaideep Chaudhary
Journal:  BMC Cancer       Date:  2009-06-07       Impact factor: 4.430

10.  Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.

Authors:  Pankaj Sharma; Swathi Chinaranagari; Divya Patel; Jason Carey; Jaideep Chaudhary
Journal:  Cancer Med       Date:  2012-08-02       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.